(NASDAQ: ATAI) Atai Life Sciences Nv's forecast annual revenue growth rate of 22.75% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.33%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Atai Life Sciences Nv's revenue in 2025 is $2,309,000.On average, 3 Wall Street analysts forecast ATAI's revenue for 2025 to be $497,907,938, with the lowest ATAI revenue forecast at $342,941,326, and the highest ATAI revenue forecast at $664,448,820. On average, 1 Wall Street analysts forecast ATAI's revenue for 2026 to be $321,507,494, with the lowest ATAI revenue forecast at $321,507,494, and the highest ATAI revenue forecast at $321,507,494.
In 2027, ATAI is forecast to generate $1,093,125,478 in revenue, with the lowest revenue forecast at $1,093,125,478 and the highest revenue forecast at $1,093,125,478.